Tufts CSDD Study Finds Adoption of Adaptive Clinical Trial Designs is IncreasingReport shows growing acceptance by pharmaceutical companies and regulatory agencies.
Promedior Presents Encouraging Results from Clinical Study of PRM-151ATS oral presentation of phase 1b data highlights potential for novel mechanism to treat fibrosis.
Patient Openness to Research Can Depend on Race and Sex of Study PersonnelResearchers have found that the race and sex of study personnel can influence a patient’s decision on whether or not to participate in clinical research.
Results of the ROTAVAC Rotavirus Vaccine Study in IndiaStatement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
Vince and Associates Clinical Research Joins the Altasciences GroupThe Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities.
Cocaine Vaccine Passes Key Testing HurdleNew anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon.
Redx Pharma Opens £10.5 Million R&D Centre in UKLiverpool-based drug discovery and development company Redx Pharma is to open a new research and development facility at AZ's Alderley Park site in Cheshire.
NIH Clinical Trial Begins for Treatment of Rare, Fatal Neurological DisorderGovernment, industry, academia, and patient groups collaborate on Niemann-Pick Type C research.
NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage TrialThe trial results appeared in the April 1 issue of the Journal of Infectious Diseases.
Galapagos Discovers Novel Candidate Drug to Treat Breast CancerGLPG1790 has high efficacy against triple-negative breast cancer.
